Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function

Experimental Biology and Medicine

Volumn 228, Issue 5, 2003, Pages 447-453

  Chen, Yen Hsu ^a,c   Yet, Shaw Fang ^a,b   Perrella, Mark A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Blood pressure; Cardiovascular; Oxidative stress

Indexed keywords

HEME OXYGENASE 1; LIPOPOLYSACCHARIDE; ENDOTHELIN 1; INTERLEUKIN 1BETA; PROTEIN BCL 2; HEME OXYGENASE; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL MODEL; BLOOD PRESSURE REGULATION; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HYPERTENSION; HYPOTENSION; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SEPSIS; SYSTOLIC BLOOD PRESSURE; ARTICLE; ENDOTOXEMIA; GENE DELETION; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; PROTEIN EXPRESSION; RENOVASCULAR HYPERTENSION; UPREGULATION; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; DRUG EFFECT; GENETICS; HEART INFARCTION; KIDNEY; METABOLISM; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE;

ANIMALIA;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; ENDOTOXEMIA; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; KIDNEY; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION;

EID: 0038545240     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/15353702-0322805-03     Document Type: Conference Paper

References (56)

1. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 61:748-755, 1968.
2. Maines MD. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2:2557-2568, 1988.
3. Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 20:543-558, 1988.
4. Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci 12:185-188, 1991.
5. Choi AMK, Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15:9-19, 1996.
6. Abraham NG, Drummond GS, Lutton JD, Kappas A. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 6:129-168, 1996.
7. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554, 1997.
8. McCoubrey WKJ, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247:725-732, 1997.
9. Otterbein LE, Choi AMK. Heme oxygenase: Colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279:L1029-L1037, 2000.
10. Ryter SW, Otterbein LE, Morse D, Choi AMK. Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance. Mol Cell Biochem 234:249-263, 2002.
11. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-1046, 1987.
12. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243:388-390, 1989.
13. Escalante B, Sacerdoti D, Davidian MM, Laniado-Schwartzman M, McGiff JC. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 17:776-779, 1991.
14. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86:213-219, 1990.
15. Martasek P, Schwartzman ML, Goodman AI, Solangi KB, Levere RD, Abraham NG. Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J Am Soc Nephrol 2:1078-1084, 1991.
16. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol 271:H1132-H1138, 1996.
17. Christou H, Morita T, Hsieh C-M, Koike H, Arkonac B, Perrella MA, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86:1224-1229, 2000.
18. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25:166-169, 1995.
19. Sylvester JT, McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res 43:429-437, 1978.
20. McGrath JJ, Smith DL. Response of rat coronary circulation to carbon monoxide and nitrogen hypoxia. Proc Soc Exp Biol Med 177:132-136, 1984.
21. Morita T, Perrella MA, Lee M-E, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92:1475-1479, 1995.
22. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91:2306-2309, 1995.
23. Wang R, Wu L, Wang Z. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 434:285-291, 1997.
24. Kaide J-I, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, Balazy M, Abraham NG, Nasjletti A. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107:1163-1171, 2001.
25. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96:2676-2682, 1995.
26. Ishizaka N, De Leon H, Laursen JB, Fukui T, Wilcox JN, De Keulenaer F, Griendling KK, Alexander RW. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 96:1923-1929, 1997.
27. Haugen EN, Croatt AJ, Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58:144-152, 2000.
28. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingel-finger JR, Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35:800-806, 2000.
29. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 38:210-215, 2001.
30. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94:10925-10930, 1997.
31. Yet S-F, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee M-E. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103:R23-R29, 1999.
32. Imai T, Morita T, Shindo T, Nagai R, Yazaki Y, Kurihara H, Suematsu M, Katayama S. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res 89:55-62, 2001.
33. Wiesel P, Patel AP, Carvajal IM, Wang ZY, Pellacani A, Maemura K, DiFonzo N, Rennke HG, Layne MD, Yet S-F, Lee M-E, Perrella MA. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 88:1088-1094, 2001.
34. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347-379, 1934.
35. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29:1025-1030, 1997.
36. Bone RC. The pathogenesis of sepsis. Ann Intern Med 115:457-469, 1991.
37. Bone RC, Grodzin CJ, Balk RA. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 112:235-243, 1997.
38. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993.
39. Yet S-F, Pellacani A, Patterson C, Tan L, Folta SC, Foster L, Lee WS, Hsieh C-M, Perrella MA. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem 272:4295-4301, 1997.
40. Pellacani A, Wiesel P, Sharma A, Foster LC, Huggins GS, Yet S-F, Perrella MA. Induction of heme oxygenase-1 during endotoxemia is downregulated by transforming growth factor-b1. Circ Res 83:396-403, 1998.
41. Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, Maemura K, LeBlanc BW, Marino K, Doerschuk CM, Yet S-F, Lee M-E, Perrella MA. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102:3015-3022, 2000.
42. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163, 1985.
43. Yet S-F, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee M-E, Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89:168-173, 2001.
44. Vulapalli SR, Chen Z, Chua BH, Wang T, Liang CS. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol 283:H688-H694, 2002.
45. Foresti R, Sarathchandra P, Clark JE, Green CJ, Motterlini R. Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: A link to apoptosis. Biochem J 339:729-736, 1999.
46. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196-1200, 2001.
47. Greabu M, Olinescu R, Kummerow FA, Crocnan DO. The levels of bilirubin may be related to an inflammatory condition in patients with coronary heart disease. Acta Pol Pharm 58:225-231, 2001.
48. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278:H643-H651, 2000.
49. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83:568-577, 1998.
50. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166:4185-4194, 2001.
51. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148-18153, 1992.
52. Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 31:335-340, 1999.
53. Pataki T, Bak I, Csonka C, Kovacs P, Varga E, Blasig IE, Tosaki A. Regulation of ventricular fibrillation by heme oxygenase in ischemic/reperfused hearts. Antioxid Redox Signal 3:125-134, 2001.
54. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno- associated virus-mediated delivery of heme oxygenase gene. Circulation 105:602-607, 2002.
55. Liu H, Song D, Lee SS. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol 280:G68-G74, 2001.
56. Seki T, Naruse M, Naruse K, Yoshimoto T, Tanabe A, Seki M, Tago K, Imaki T, Demura R, Demura H. Induction of heme oxygenase produces load-independent cardioprotective effects in hypertensive rats. Life Sci 65:1077-1086, 1999.